Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03667781 · ClinicalTrials.gov registry record
Therapeutic Drug Monitoring of Cardiac Medications
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Terminated
- Registry status
- 77
- Enrollment target
NCT03667781: Clinical Trial study, sponsored by University of Texas Southwestern Medical Center.
NCT03667781 is a clinical trial that was terminated before completion, run by University of Texas Southwestern Medical Center. The registered enrollment target is 77 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03667781 was terminated before completion, sponsored by University of Texas Southwestern Medical Center.
- TERMINATED
- Registry status
- 77 participants
- Enrollment target
Study Summary
The investigators will interview patients and providers of patients who have hypertension and are seen in cardiology clinic about ways to discuss therapeutic drug monitoring with patients. The investigators will use these interviews to crease discussion tools to discuss therapeutic drug monitoring. The investigators will then draw one venous blood sample in a different group of patients who are seen in interventional clinic for 1 month followup after PCI. The investigators will assay this blood for therapeutic drug monitoring and will provide the results to their providers for discussion at their regularly scheduled followup cardiology visit. The investigators will have the patients and providers fill out a survey afterwards to determine how they viewed therapeutic drug monitoring.
Primary Outcome
Assessed by survey
Interventions
- DIAGNOSTIC_TEST Therapeutic drug monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2023-05-14 |
Why NCT03667781 stopped before completion
NCT03667781 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 77 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Therapeutic drug monitoring is the first listed.
NCT03667781 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03667781 about?
NCT03667781 is a clinical study titled "Therapeutic Drug Monitoring of Cardiac Medications". The investigators will interview patients and providers of patients who have hypertension and are seen in cardiology clinic about ways to discuss therapeutic drug monitoring with patients. The investigators will use these interviews to crease discussion tools to discuss therapeutic drug monitoring. ...
What is the current status of trial NCT03667781?
This trial is currently terminated. The enrollment target is 77 participants. The study started on 2018-08-01. Estimated completion is 2023-05-14.
What interventions are being tested in trial NCT03667781?
The interventions under investigation include: Therapeutic drug monitoring (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03667781?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02127398 · 77 participants · Phase 2
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
- NCT04159103 · 77 participants · Phase 1
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- NCT04683003 · 77 participants · Phase 3
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- NCT05004116 · 77 participants · Phase 1
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI